Martina Vendrame

Dr. Martina Vendrame

orcid

Research Focus & Metrics

Academic Career Length

17Years (2010-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 May 2013 in Sleep and Breathing
Verified
Journal Article
Closed access
PDF file
MVMartina Vendrame
Martina Vendrame
SJStephanie Jackson
Stephanie Jackson
SSSana Syed
Sana Syed
KSKothare Sanjeev
Kothare Sanjeev
SASanford H. Auerbach
Sanford H. Auerbach

11 May 2012 in Epilepsia
Verified
Journal Article
Closed access
PDF file
SRSriram Ramgopal
Sriram Ramgopal
ASAneri Shah
Aneri Shah
MZMarcin A Zarowski
Marcin A Zarowski
MVMartina Vendrame
Martina Vendrame
MGMatthew Gregas
Matthew Gregas
KSKothare Sanjeev
Kothare Sanjeev

27 May 2011 in American Journal of Medical Genetics Part A
Verified
Journal Article
Closed access
PDF file
MZMarcin A Zarowski
Marcin A Zarowski
MVMartina Vendrame
Martina Vendrame
MIMira Irons
Mira Irons
KSKothare Sanjeev
Kothare Sanjeev

1 August 2014 in Epilepsy & Behavior
Verified
Journal Article
Closed access
IFIván Sánchez Fernández
Iván Sánchez Fernández
MVMartina Vendrame
Martina Vendrame
KKKush Kapur
Kush Kapur
JKJacqueline Klehm
Jacqueline Klehm
SUSerife Uysal
Serife Uysal
TLTobias Loddenkemper
Tobias Loddenkemper

3 April 2024 in Cureus
Verified
Journal Article
Open access
ERErafat D Rehim
Erafat D Rehim
MVMartina Vendrame
Martina Vendrame
Narcolepsy Type 1 is a sleep disorder, with cataplexy as its cardinal feature, characterized by sudden decrease or loss of muscle tone triggered by strong emotions. Cataplexy can be misdiagnosed as epileptic seizures given its clinical similarity to atonic seizures. The low prevalence of the disease added another layer of complexity in providing timely and accurate diagnosis. We report a case of a young man with recurrent episodes of falling and an inability to respond, initially misinterpreted as epileptic seizures due to findings in routine electroencephalography (EEG). Anti-seizure medications were ineffective, and subsequent ambulatory EEG revealed no epileptic activity during events. A detailed history uncovered symptoms of cataplexy and daytime sleepiness, leading to the correct diagnosis of narcolepsy type I confirmed by polysomnogram (PSG) and mean sleep latency test (MSLT). Discontinuation of anti-seizure medications and treatment with venlafaxine successfully resolved cataplexy. The case highlights the importance of a thorough clinical history in distinguishing cataplexy from seizures, as well as the caution against relying solely on EEG findings for epilepsy diagnosis. Ambulatory EEG can help exclude epileptic events, and PSG with MSLT are necessary to confirm narcolepsy type I.

1 March 2025 in Journal of Clinical Sleep Medicine
Verified
Journal Article
Closed access
RJRena Y. Jiang
Rena Y. Jiang
RRRoger Rochart
Roger Rochart
ICIrene Chu
Irene Chu
SDShae Duka
Shae Duka
MVMartina Vendrame
Martina Vendrame
We aimed to characterize clinical features, comorbidities and polysomnographic characteristics of a large cohort of patients with narcolepsy. We undertook a retrospective chart and polysomnographic review of all patients with a diagnosis of narcolepsy type 1 (NT1) or narcolepsy type 2 (NT2) seen within the Lehigh Valley Health Network between 2000 and 2022. We found 304 cases with a diagnosis of narcolepsy (52 NT1, 252 NT2), based on International Classification of Sleep Disorders, third edition criteria. Compared to NT2, patients with NT1 had younger diagnosis age (24.5 versus 27.4 years, p=0.03), shorter diagnostic gap (3.0 versus 4.6 years, p=0.002), more frequent sleep paralysis (55.8% versus 19.4%, p<0.0001) and hypnagogic hallucinations (46.2% versus 25.4%, p=0.003), and higher Epworth Sleepiness Scale (ESS) scores (17.8 versus 16.7, p=0.02). The most common comorbid sleep disorders were breathing disorders (17.4%) and insomnia (15.5%). Migraine was the most common neurological disorder. Depression was more common in NT2 than NT1 [12 (23.1%) versus 94 (37.3%), p=0.05]. On the Multiple Sleep Latency Test, patients with NT1 had more sleep onset REM periods (SOREMPs) than patients with NT2 (≥3 SOREMPs in 59.2% versus 26.9%, p<0.0001). Only in NT2, hypnagogic hallucinations and higher ESS scores were associated with higher numbers of SOREMPs (p=0.0277 and p=0.0179 respectively). This is one of the largest monocentric studies to date of patients with narcolepsy and confirms the frequent comorbidities of narcolepsy. Specific clinical characteristics and comorbidities may help differentiate NT1 from NT2.